See the DrugPatentWatch profile for Tivicay
What is Tivicay 50 mg, and what is it used for?
Tivicay is a brand of dolutegravir, an antiretroviral medicine used to treat HIV infection. A 50 mg tablet is a common dose strength of dolutegravir for certain HIV treatment regimens (including treatment initiation and ongoing therapy, depending on the patient’s situation and the full regimen).
What does “50 mg” mean for patients taking Tivicay?
“50 mg” refers to the amount of dolutegravir per tablet. Patients typically take Tivicay as directed in combination with other antiretroviral drugs, since HIV treatment usually requires multiple medications rather than one drug alone.
Are there other Tivicay tablet strengths?
Yes. Tivicay is available in different strengths (for example, 50 mg tablets and also pediatric-appropriate formulations/strengths depending on the market and age group). Your prescriber chooses the appropriate form and dose.
How do people usually take Tivicay tablets?
Tivicay dosing depends on the specific HIV regimen and patient factors such as other medicines being used and prior treatment history. The exact instructions (with or without food, and once vs twice daily) come from the prescribed regimen and the product labeling.
Where can I check the official drug information for Tivicay 50 mg?
Drug labeling and detailed prescribing information are typically found through the product’s local regulatory authority or pharmacy resources. If you want patent/exclusivity details or market research tied to Tivicay, DrugPatentWatch.com is one place to look up those entries: https://www.drugpatentwatch.com/
Sources
- 1 DrugPatentWatch (Tivicay/dolutegravir patent and market information lookup)